MindMed NR Most here have probably heard the news for MindMed. If you haven't, this news could (should) be fantastic for MBio as well. Being on the radar of the FDA in the US means cash infusions and a much more streamlined path to production should they continue to have solid results.
With the similarity in results, the potential that creates for MBio can't be overstated. If these next results for cancer patients that are soon to be released and the subsequent 2b trial now approved offer the same, the sky is the limit. All Mbio needs is to get noticed. Those holding the shares are currently holding them tight to the chest as evidenced in recent trading. All of this is absolutely fantastic for investors
https://www.marketwatch.com/story/mindmeds-stock-jumps-24-after-fda-grants-breakthrough-designation-to-lsd-therapy-for-a-form-of-anxiety-c5d230c5